RxDoctor Payments DataLook up a doctor →

Tracey Carpenter, NP

Nurse Practitioner · Chesterfield, MONPI 1083166433

Payments from drug & device makers

$47,028in general payments, 2019–2025

Across 771 payments — averaging $61.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$39K
  • Pfizer$910
  • Supernus Pharmaceuticals, Inc.$899
  • Boston Scientific$518
  • Novartis$501
  • Amgen$431
  • plus $5K from 40 others

What the payments were for

  • Speaking & faculty fees$33,32071%
  • Food & beverage$13,67729%
  • Education$310%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,028 in reported general payments places this provider in the 95th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$176,712
Medicare patients
95
Services billed
24,416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant41$48,942
Aimovig AutoinjectorErenumab-Aooe32$37,733
QuliptaAtogepant12$12,094
Sumatriptan Succinate44$2,692
Gabapentin65$1,718
Memantine Hcl ErMemantine Hcl23$1,688
Levetiracetam14$1,148
Topiramate50$537
RizatriptanRizatriptan Benzoate26$442
Nortriptyline Hcl29$408
Prochlorperazine Maleate13$195
Methylprednisolone23$158
Ondansetron Hcl15$133
Folic Acid12$47

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$39,072$61,03553 claims
Upsher-smith Laboratories LLCTopiramate$19$53750 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Chesterfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →